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Abstract
Background: Serum anti-Müllerian hormone (AMH) had been proposed as a marker of ovarian reserve. The aim of
this study was to evaluate the impact of endometrioma and laparoscopic cystectomy on ovarian reserve as
measured by serum AMH levels.
Methods: A total of 1,642 patients were recruited in this retrospective analysis. Control group (group 1) included
1,323 infertility patients without endometrioma. Endometrioma group (group 2) included 141 patients with ovarian
endometrioma. Previous cystectomy group (group 3) included 147 patients who underwent unilateral or bilateral
laparoscopic cystectomy due to ovarian endometrioma more than 6 months before enrollment. Current
cystectomy group (group 4) included 31 patients who underwent cystectomy during study period. Serum anti-
müllerian hormone (AMH) levels were measured upon enrollment with all patients. For patients in group 4, AMH
levels were measured before and 3 months after cystectomy.
Results: Mean AMH level of patients in control group was significantly higher than that of endometrioma group
or previous cystectomy group in each age subgroup, while the mean serum AMH level of the endometrioma
group was also significantly higher than that of the previous cystectomy group in each age subgroup. The mean
AMH level was significantly lower in patients with previous bilateral cystectomy compared to that of patients with
unilateral cystectomy. The mean serum AMH level was also significantly lower in patients with bilateral
endometrioma compared to that of patients with unilateral endometrioma. In group 4, mean AMH level
significantly decreased from 3.95 +/- 0.42 preoperation to 2.01 +/- 0.21 ng/ml at 3-month postoperation.
Conclusions: Both ovarian endometrioma and cystectomy are associated with a significant reduction on ovarian
reserve. Bilateral endometrioma exerts a more profound negative impact on ovarian reserve than unilateral
endometrioma, regardless of either conservative or surgical intervention.
Background
Endometrioma is one of the most commonly encoun-
tered diagnoses in ovarian surgery and may be present
in up to 17-44% of patients with endometriosis [1-3].
Ovarian endometriomas are usually associated with the
symptoms of dysmenorrhea, chronic pelvis pain, dyspar-
eunia, and infertility. Previous studies have demon-
strated that endometriomas can negatively affect the
rate of spontaneous ovulation [4], as well as reducing
the amount of follicular number and activity in the adja-
cent ovarian tissues [5]. Based on articles review, the
current 2008 ESHRE guidelines on endometriosis
recommended that laparoscopic ovarian cystectomy is
advised if an ovarian endometrioma ≥ 4 cm in diameter
is present and hereby to confirm the diagnosis histologi-
cally, improve access to follicles, and possibly improve
ovarian response [6-8]. However, some studies reported
that ovarian reserve was damaged after excision of endo-
metriomas [4,9-11] and therefore, ESHRE guidelines also
recommended that these patients should be counseled
* Correspondence: mmh40@ms2.mmh.org.tw
† Contributed equally
1Department of Obstetrics and Gynecology, Mackay Memorial Hospital,
Taipei, Taiwan
Full list of author information is available at the end of the article
Hwu et al. Reproductive Biology and Endocrinology 2011, 9:80
http://www.rbej.com/content/9/1/80
© 2011 Hwu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.on the risk of reduced ovarian function after surgery.
With the difficulties to evaluate the ovarian reserve,
most of the previous studies used ovarian responses to
gonadotropins as a marker to assess the ovarian reserve
after endometrioma cystectomy [4,9-11].
In the past two decades, serum anti-Müllerian hor-
mone (AMH), day 3 FSH, E2, and inhibin B levels have
been proposed as markers of ovarian reserve [12-14].
However, inhibin B, FSH, and E2 levels are all involved
in the pituitary-ovary axis negative feedback [15] that
great variations are observed during menstrual cycle. In
contrast, serum AMH levels were reported to be stable
throughout the menstrual cycle [13]. La marca et al.
recommended that AMH was a superior marker for pre-
dicting ovarian response over either age, FSH, or inhibin
B[ 1 4 ] .T h e r e f o r e ,A M Hm a ya l s ob eav e r yi n f o r m a t i v e
marker regarding the degree of ovarian reserve damage
due to endometrioma or ovarian cystectomy. However,
very few studies have assessed the damage on ovarian
reserve induced by ovarian endometrioma or cystectomy
using serum AMH levels. The aim of this study was to
evaluate the impact of endometrioma and laparoscopic
cystectomy on ovarian reserve as measured by serum
AMH levels. In addition, the differences in ovarian
reserve impairment between unilateral and bilateral
endometriomas and cystectomy were also investigated.
Methods
Patients
A total of 1,642 subjects were recruited in this retro-
spective study. Enrolled were infertility patients with or
without ovarian endometrioma between the age of 22 to
46-year-old visiting MacKay Memorial Hospital between
January 2007 and March 2010. The study protocol was
approved by the Institutional Review Board (IRB) of
Mackay Memorial Hospital in Taipei, Taiwan. Patients
with subfertility problem were recruited after evaluation
for infertility, including hysterosalpingography, endo-
crine evaluation, and ultrasonography for female
patients, and semen analysis for their male partners.
Serum levels of endocrines including total testosterone,
prolactin, 17-hydroxyprogesterone (17-HP), dehydroe-
piandrosterone sulfate (DHEAS), free thyroxine (T4),
thyroid-stimulating hormone (TSH), and AMH were
obtained in the early follicular phase of menstrual cycle.
The exclusion criteria were as follows: patients with [1]
polycystic ovarian syndrome according to the Rotterdam
criteria [16], [2] ovarian malignant diseases, [3] intake of
hormonal medications within 3 months before enroll-
ment, such as oral contraceptive pills, GnRH analogue or
danazol treatment, [4] a body mass index (BMI) higher
than 30 kg/m
2, [5] evidence of endocrine disorders such
as hyperprolactinemia, congenital adrenal hyperplasia,
Cushing’s syndrome, or adrenal gland tumor.
Subjects were divided into four groups according to
the presence or status of endometrioma (Table 1).
Group 1 (control group) (n = 1,323): patients were
recruited from outpatient department due to subfertility
problem. No ovarian endometrioma were found using
ultrasonography in the patients of this group. Serum
AMH levels were obtained upon enrollment. Group 2
(endometrioma group) (n = 141): Patients with unilat-
eral or bilateral ovarian endometrioma with a diameter
of at least 3 cm was diagnosed by clinical and ultrasono-
graphy findings with no surgical intervention during
enrollment. Group 3 (endometrioma with previous
cystectomy group) (n = 147): Patients who underwent
unilateral or bilateral laparoscopic cystectomy due to
ovarian endometrioma more than 6 months before
enrollment were recruited. Serum AMH levels were
obtained at time of enrollment. Serum AMH levels were
not measured before the previous laparoscopic cystect-
omy. Group 4 (current cystectomy group) (n = 31): Uni-
lateral ovarian endometrioma with a diameter of at least
3 cm was diagnosed upon enrollment and laparoscopic
unilateral cystectomy was performed aftermath. Ovarian
endometrioma was confirmed by histology specimen
obtained from laparoscopic cystectomy. Serum AMH
levels were obtained both before and 3 months after
laparoscopic cystectomy (Table 1). Patients with bilateral
endometrioma undergoing bilateral cystectomy were
excluded in this current cystectomy group.
Serum AMH measurements
Serum AMH levels were measured in the early follicular
phase of menstrual cycle. For groups 1, 2, and 3, serum
AMH levels were obtained at outpatient department
upon enrollment. For group 4, AMH levels were mea-
sured preoperatively upon enrollment and 3 months
postoperatively. AMH levels were measured using a
commercial enzyme-linked immunosorbent assay kit
(ELISA, Diagnostic Systems Laboratories, Webster, TX)
and the lowest detectable level of AMH distinguishable
from zero was 0.006 ng/ml. The intra-assay and inter-
assay coefficients of variation were 4.6% and 8.0%
respectively.
Diagnosis of ovarian endometrioma
All recruited patients underwent transvaginal ultrasono-
graphy evaluation using a Toshiba Nemio SSA-550A
System. The color and power Doppler imaging evalua-
tion was also used upon need. According to Guerriero’s
study [17] and other previous reports, criteria for ultra-
sound diagnosis of endometrioma were: [1] cystic struc-
ture with homogenous low-level internal echoes without
papillary proliferations associated with poor vasculariza-
tion, and [2] cystic structure with homogenous low-level
internal echoes with an echogenic portion in which no
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nation was performed 1-2 months aftermath to exclude
spontaneously resolving hemorrhagic cyst.
Laparoscopic cystectomy techniques
All laparoscopic cystectomy operations were performed
under general anesthesia during the early or middle fol-
licular phase of menstrual cycle. The cleavage plane
between the cyst wall and the normal ovarian tissue was
identified after the cyst wall was incised with monopolar
scissors. Then, the cyst wall was completely stripped off
from the normal ovarian tissue by traction and opposite
traction with two grasping forceps. Hemostasis was per-
formed with bipolar forceps electrocoagulation. All
endometrioma specimens obtained from operation were
submitted for pathology examination.
Statistical analysis
Data were expressed as mean ± standard error of mean
(SEM). One way analysis of variance (ANOVA) followed
by the post hoc test was employed to compare the sig-
nificance of differences in serum AMH levels between
the control, endometrioma and cystectomy groups. The
relationships between the changes in serum AMH levels
and patient’s age were analyzed using bivariate correla-
tion analysis with Pearson coefficient. The relationships
were presented graphically by regression curve estima-
tion using Medcalc and SigmaPlot software.
Student’s t-test was used to compare the differences in
AMH levels between unilateral and bilateral endome-
triomas and cystectomy. Paired t-test was used to com-
pare the differences between the sampling points
(preoperative and 3 months postoperative) for the
changes in AMH levels of group 4. The statistical soft-
ware package SPSS version 12.0 (SPSS Inc., Chicago, IL)
and SigmaPlot (Systat Software Inc., Chicago, IL) were
used. All results were considered statistically significant
at P < 0.05.
Results
The effect of endometrioma and previous cystectomy on
serum AMH levels
A total of 1,642 patients were included in this study,
with a mean age of 33.91 years at their initial visit
(range: 22-46 years), and their clinical characteristics are
shown in Table 1. The serum levels of AMH in relation
to age in the control group, endometrioma group, and
previous cystectomy group are all shown in Figure 1. In
control group, serum AMH level was significantly nega-
tively correlated with increasing age of the patients (r =
-0.421, P < 0.001) (Figure 1). Similar to control group,
serum AMH levels were also significantly negatively cor-
related with increasing age in both endometrioma group
(r = -0.364, P < 0.001) and previous cystectomy group
(r = -0.266, P < 0.01) (Figure 1). The mean ages of
Table 1 Clinical characteristics of the patients in each group
Number
of
patients
Age
(Mean
± SD)
(Range)
Clinical Characteristics Laparoscopic Cystectomy Time of serum AMH
collection
Control Group
(Group 1)
1,323 34.09 ±
4.34
(22-46)
Tubal factor
Male factor
Unexplained infertility
nil At time of
enrollment
Endometrioma
Group (Group 2)
141 33.27 ±
4.09
(23-44)
Endometrioma > 3 cm diagnosed by
ultrasound and clinical diagnosis
nil At time of enrollment
Previous
Cystectomy Group
(Group 3)
147 33.88 ±
4.29
(22-47)
Previous laparoscopic cystectomy due to
ovarian endometrioma
Cystectomy performed more
than 6 months before
enrollment
At time of enrollment
Current
Cystectomy Group
(Group 4)
31 31.14 ±
3.96
(22-39)
Unilateral endometrioma with
laparoscopic cystectomy performed after
enrollment
Unilateral cystectomy was
performed after enrollment
Before cystectomy and 3
months after cystectomy
Figure 1 The impact of endometrioma and previous
cystectomy on serum AMH levels in relation to age. The
estimated curves of serum AMH levels in relation to age represent
the patients in control group, endometrioma group and previous
cystectomy group respectively. Serum AMH level was significantly
negatively correlated with increasing age in all groups.
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cant difference was found regarding the mean ages of
patients between the groups (Table 1).
To assess the effect of endometrioma and previous
cystectomy on serum AMH levels, one way analysis of
variance (ANOVA) was applied and it presented signif-
icant differences in the mean serum AMH levels
among the control group, endometrioma group, and
previous cystectomy group in each age subgroup
(Table 2) (Figure 2). Post hoc test showed that the
mean serum AMH level of patients in control group
was significantly higher than that of the endometrioma
group or previous cystectomy group in each age sub-
g r o u p( T a b l e2 )( F i g u r e2 ) .T h em e a ns e r u mA M H
level of the endometrioma group was also significantly
higher than that of the previous cystectomy group in
each age subgroup (Table 2) (Figure 2).
The impact of unilateral or bilateral endometrioma on
serum AMH levels
To evaluate the impact of unilateral or bilateral endo-
metrioma on serum AMH levels in endometrioma
group (group 2) (n = 141), the mean serum AMH level
of patients with bilateral endometrioma (n = 32) was
compared with that of patients with unilateral endo-
metrioma (n = 109). Figure 3 shows the mean serum
AMH level was significantly lower in patients with
bilateral endometrioma compared to that of patients
with unilateral endometrioma (1.56 ± 0.24 (SEM) vs.
2.45 ± 0.17 ng/ml, P < 0.05) (Figure 3). The mean ages
of patients with unilateral and bilateral endometrioma
were 33.4 ± 4.1 (SD) and 32.9 ± 4.2 respectively. No
significant difference was found regarding the mean
ages of patients between the unilateral and bilateral
endometrioma groups. Notably, four women younger
than 38 years (range: 33-37 years) in endometrioma
group had serum AMH levels lower than 0.5 ng/ml.
One woman was diagnosed with a 5-cm diameter
endometrioma in her left ovary. The other three
women had bilateral endometriomas larger than 4 cm
in diameter.
The impact of unilateral or bilateral cystectomy on serum
AMH levels
To compare the effect of unilateral and bilateral cystect-
omy on serum AMH levels in previous cystectomy
group (group 3), the mean serum AMH level in patients
with bilateral cystectomy (n = 66) was compared to that
in patients with unilateral cystectomy (n = 81). Figure 4
shows the mean serum AMH level was significantly
lower in patients treated with bilateral cystectomy than
in patients treated with unilateral cystectomy (1.01 ±
0.11 vs.1.48 ± 0.14 ng/ml, P < 0.05) (Figure 4). The
mean ages of patients with unilateral and bilateral pre-
vious cystectomy were 33. 6 ± 4.1 (SD) and 34.2 ± 4.5
respectively. No significant difference was found regard-
ing the mean ages of patients between the unilateral and
bilateral previous cystectomy groups. Among the 147
women in previous cystectomy group, two women
(1.4%) younger than 38 years had ovarian failure 1 year
after bilateral cystectomy. Another eight women (5.4%)
younger than 38 years (range: 28-37 years) with severely
impaired ovarian reserve (AMH <0.05 ng/ml, day 3 FSH
>15 mIU/ml) were identified. Seven of these eight
women underwent bilateral cystectomy. Another woman
underwent unilateral cystectomy.
The changes between the preoperative and 3-month
postoperative serum AMH levels
To study the extent of cystectomy damage on ovarian
reserve, the preoperative and 3-month postoperative
serum AMH levels were obtained from 31 patients who
underwent cystectomy due to endometrioma (current
cystectomy group) (group 4). Figure 5 shows the mean
serum level significantly decreased from 3.95 ± 0.42 ng/
ml (SEM) before cystectomy to 2.01 ± 0.21 ng/ml 3-
month postoperation (P < 0.01) (Figure 5).
Discussion
In this study, the results demonstrated that mean serum
AMH level in patients with endometrioma was signifi-
cantly lower than that of patients in the control group.
Additionally, the mean serum AMH level in patients
Table 2 Comparison of mean serum AMH levels (ng/mL) between the groups according to age
Age Control Group Endometrioma Group Cystectomy Group P Value
(ANOVA test)
≦30 3.94 ± 0.12 2.97 ± 0.31
b 1.74 ± 0.25
a, c <0.001
31-35 3.31 ± 0.08 2.34 ± 0.19
d 1.53 ± 0.14
a, c <0.001
≧36 1.98 ± 0.08 1.35 ± 0.19
b 0.53 ± 0.07
a, c <0.001
Values are mean ± SEM.
Post-hoc test:
a. P < 0.001;control group vs. cystectomy group.
b. P < 0.05; control group vs. endometrioma group.
c. P < 0.05; endometrioma group vs. cystectomy group.
d. P < 0.001; control group vs. endometrioma group.
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than patients with endometrioma (without previous
cystectomy) (Figures 1 and 2) (Table 2). Based on our
results, we suggest that ovarian endometrioma per se is
associated with reduced ovarian reserve, and laparoscopic
cystectomy can further exerted significant damage on
ovarian reserve. Meanwhile, bilateral endometriomas had
a more profound impact on serum AMH levels than uni-
lateral endometriomas, regardless of either surgical
cystectomy or conservative management (Figures 3, 4, 5).
The effect of endometrioma-associated damage on ovar-
ian reserve is very difficult to assess and quantify. In the
previous studies, the damaging effect of endometrioma per
se on ovarian reserve was assessed by histological study
Figure 2 The effect of endometrioma and previous cystectomy on serum AMH levels in each age subgroup. The mean serum AMH level
of patients in the control group was significantly higher than that of the patients in the endometrioma group or previous cystectomy group in
each age subgroup. Data are shown as the mean ± SEM. One way analysis of variance (ANOVA) followed by the post hoc test was employed to
compare the significance of differences. *P < 0.001, control group vs. cystectomy group. ** P < 0.05, control group vs. endometrioma group. # P
< 0.05, endometrioma group vs. cystectomy group. ## P < 0.001, control group vs. endometrioma group.
Figure 3 The impact of unilateral or bilateral endometrioma on serum AMH levels. (A) The estimated curves of serum AMH levels in
relation to age for patients with unilateral endometrioma and bilateral endometriomas. (B) The mean serum AMH level was statistically
significantly lower in patients with bilateral endometrioma compared to that in patients with unilateral endometrioma. Data are shown as the
mean ± SEM (*P < 0.05).
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siveness to gonadotropins as the surrogate marker [11,20].
A meta-analysis concluded that ovarian endometrioma
was associated with significantly reduced number of
retrieved oocytes and developing follicles after ovarian sti-
mulation [21]. In our study, we used serum AMH levels to
assess the ovarian reserve. The mean serum AMH level of
the 141 patients with endometrioma (group 2) was signifi-
cantly lower compared to the 1,323 patients without endo-
metrioma (control group) (Figures 1, 2, Table 2). Shebl et
al. reported that AMH levels were significantly lower in
patients with severe endometriosis than in the control
group [22]. In agreement with Shebl’sr e p o r t s ,w ea l s o
found that patients with ovarian endometriomas had sig-
nificantly lower serum AMH levels compared with
patients without endometriomas. These results are compa-
tible with those of the previous reports that showed the
presence of endometrioma per se may damage the ovarian
reserve measured by antral follicle count or responsiveness
to gonadotropins [11,19,21].
To illustrate the difference in the adverse effect on
ovarian reserve between unilateral and bilateral endome-
triomas, our results showed mean serum AMH level
was significantly lower in patients with bilateral endo-
metriomas than those with unilateral endometriomas
(Figure 3). Based on the results in this study and pre-
vious reports, we suggest that the presence of endome-
trioma per se exerts damage on ovarian reserve.
Moreover, bilateral endometriomas exert greater damage
on ovarian reserve than unilateral endometriomas.
The mechanism of endometrioma inducing ovarian
reserve damage is still elusive. Maneschi et al. reported
that endometrioma was associated with microscopic
alterations of the follicular and vascular patterns [5].
The number of follicles was reduced and vascular net-
work was impaired. Maneschi et al. concluded that the
Figure 4 The impact of unilateral or bilateral cystectomy on serum AMH levels. (A) The estimated curves of serum AMH levels in relation
to age for patients with previous unilateral cystectomy and bilateral cystectomy group. (B) The mean serum AMH level was statistically
significantly lower in patients with previous bilateral cystectomy than those with unilateral cystectomy. Data are shown as the mean ± SEM. (*P
< 0.05).
Figure 5 The impact of cystectomy on serum AMH levels 3 months after operation. (A) Changes in serum AMH levels before and 3
months after laparoscopic unilateral cystectomy in 31 patients with ovarian endometrioma. (B) The mean serum AMH level significantly
decreased 3 months after laparoscopic cystectomy in 31 patients with ovarian endometrioma. Data are shown as the mean ± SEM. (**P < 0.01).
Hwu et al. Reproductive Biology and Endocrinology 2011, 9:80
http://www.rbej.com/content/9/1/80
Page 6 of 8ovarian cortical tissue alterations could be related to
either the inflammatory response to the endometriosis
implants or to the toxic nature of the cystic fluid [5].
Meanwhile, Fauvet et al. discovered an increased pro-
apoptotic protein expression (bax and p21) in endome-
triomas compared with benign ovarian tumors [23].
Future study is needed to elucidate the mechanisms of
ovarian reserve damage induced by endometrioma.
The real amount of surgery-mediated ovarian reserve
damage can not be measured directly. In the previous
reports, ovarian responsiveness to gonadotropin hyper-
stimulation, ovarian volume, and antral follicle count
(AFC) have been used as the marker for assessing ovar-
ian reserve damage [10,21,24-26]. Nonetheless, AFC by
transvaginal ultrasound can not be used in women
without sexual experience. In the literature, ovarian
responsiveness is the most often used marker of ovar-
ian reserve. However, there is controversy about the
damaging effect of cystectomy on ovarian responsive-
ness to hyperstimulation. Some studies have found a
reduced responsiveness to hyperstimulation after
cystectomy [20,25-31] andm o s to ft h e mc o n c l u d e d
that laparoscopic endometrioma cystectomy contri-
butes to the reduction of ovarian reserve. In the cur-
rent study, serum AMH level was used to replace
ovarian responsiveness as the marker of ovarian
reserve damage induced by cystectomy. In the previous
reports, only a few studies have evaluated the ovarian
reserve damage using serum AMH levels in women
undergoing endometrioma cystectomy [32-34]. Tsolaki-
dis et al. reported that the mean serum AMH level was
significantly reduced 6 months after surgery [32].
Chang et al. also observed a significant decrease in
serum AMH levels 3 months after laparoscopic
cystectomy [33]. Findings of the current study are in
a g r e e m e n tw i t ht h e s er e p o r t s[ 3 2 , 3 3 ]t h a ti ts h o w e da
significant reduction in serum AMH levels in 31
patients 3 months after cystectomy (Figure 5).
During cystectomy, it is sometimes difficult to identify
and separate the cleavage plane between the cyst wall
and adjacent ovarian cortex tissue due to fibrotic adhe-
sion. Cystectomy using the stripping technique usually
leads to removal of normal primary follicles and damage
of ovarian reserve [35,36]. Furthermore, bipolar coagula-
tion at seriously bleeding sites close to ovarian hilus
also leads to destruction of the ovarian blood supply
and reduced ovarian reserve [24,37]. Excessive bipolar
coagulation and inadvertent removal of normal ovarian
tissues adhesive to endometrioma cyst wall may contri-
bute to lowered AMH levels after cystectomy in this
study (Figure 5).
The current study also discovered that patients under-
going bilateral cystectomy for endometrioma had signifi-
cantly lower AMH levels compared with patients
receiving unilateral cystectomy (Figure 4). Comparable
with our results, previous studies also reported that a
mean number of retrieved oocytes was significantly
reduced and IVF outcome was significantly impaired in
patients who have undergone bilateral cystectomy than
unilateral cystectomy [9,10,30]. Busacca et al. reported
that patients who operated for bilateral endometrioma
had a prevalence of 2.4% ovarian failure immediately
after surgery [9]. Similar to previous reports [9,10], we
found that two out of 144 women (1.4%) had ovarian
failure 1 year after bilateral cystectomy. Another eight
out of 144 women (5.4%) younger than 38 years had
severe ovarian reserve damage after cystectomy. These
eight women had very poor fertility outcomes and could
experience ovarian failure in the near future. In the
endometrioma group, we identified four women with
endometriomas younger than 38 years who had very
low serum AMH levels (<0.5 ng/ml). These four women
may encounter a high risk of impending ovarian failure
after cystectomy. To reduce such risk, it is imperative to
assess the ovarian reserve before cystectomy in women
with ovarian endometrioma. As women with ovarian
endometrioma and a very low serum AMH level are
expected to be at high risk of impending ovarian failure
after cystectomy, IVF treatment before cystectomy may
offer better pregnancy outcome for them.
Conclusions
In conclusion, the results of this study demonstrated the
following observations. First, ovarian endometrioma is
associated with a reduced ovarian reserve measured by
serum AMH levels. Second, laparoscopic cystectomy
further exerted a significant negative impact on ovarian
reserve measured by serum AMH levels in both short
and long term observations. Third, bilateral endometrio-
m a sh a dam o r ep r o f o u n di m p a c to no v a r i a nr e s e r v e
than unilateral endometriomas did, regardless of either
conservative or surgical intervention.
For counseling of patients with ovarian endometrioma,
it is imperative to identify patients with poor ovarian
reserve before surgery. Assessment of ovarian reserve by
serum AMH levels before cystectomy may help to pre-
vent ovarian failure after cystectomy. The results of this
study suggest that serum AMH level should be consid-
ered as a clinical routine test in patients with ovarian
endometrioma before cystectomy counseling. Further
large scale well-designed clinical trials are in demand to
confirm this suggestion.
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